RESVERATROL MARKET ANALYSIS

Resveratrol Market, by Application (Cosmetics, Dietary Supplements, Pharmaceutical, and Others), by Dosage Form (Tablet, Capsule, and Liquid), by Distribution Channel (Retail Channel, Online Channels and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published In : Nov 2018
Code : CMI2267
Pages :150
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Asia Pacific is expected to be a potential growth region for resveratrol market during the forecast period, owing to positive decisions by regulatory bodies towards adoption of resveratrol, which will support growth of the market. For instance, in 2013, Japanese Ministry of Health, Labor and Welfare following request of Evolva Holding SA, issued a notice that resveratrol should be classified into ‘non-drug’ material group. This decision is expected to significantly enhance the accessibility for the products in Japan. Such decisions by regulatory bodies are expected to significantly drive growth of Asia Pacific resveratrol market during the forecast period.

Furthermore, Europe resveratrol market is expected to show good growth during the forecast period, owing to strategic mergers and acquisitions by key players to widen its product portfolio with resveratrol-based products. For instance, in 2012, Evolva SA, a Switzerland-based biotech firm, acquired Fluxom A/S resveratrol business for US$ 713,103 (€ 550,000).